Get notified when TPST files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsRed Flags Detected
- Going Concern (worsened) — Going-concern doubt persists; cash runway shortened from $21.5M to $1.8M, now under 12 months despite Factor credit line.
Tempest cash drops to $1.8M; Factor credit line uncertain, strategic-sale process removed
Filed May 14, 2026 · Period ending March 31, 2026 · Compared to 10-Q May 13, 2025 · ~1 min read
Key Changes
-
high
Cash plunged from $21.5M to $1.8M year-over-year, with runway under 12 months. Going-concern doubt persists despite new Factor credit line.
Risk Factors: Cash position verify on EDGAR → -
high
Closed Asset Acquisition in February 2026 with Factor credit line providing up to $20M over 18 months; $13.8M available but company warns of 'significant uncertainty' meeting access conditions.
Risk Factors: Factor credit line verify on EDGAR → -
high
Strategic-alternatives process announced April 2025 (including potential merger, sale, or wind-down with MTS Health Partners as advisor) no longer disclosed, suggesting conclusion or abandonment.
Risk Factors: Strategic alternatives verify on EDGAR →
1 more material change behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (ADMT 10-K) is open in full — no account needed.
Partner
Trade TPST commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Source-verified from EDGAR · Narrative written by AI · May 25, 2026 · How we verify